Transfer Factor TFI for Recurrent Infections

We are testing a new treatment for people with frequent respiratory or urinary tract infections and recurrent herpes. The study aims to see if it can help reduce the number of new infections.

6-12 monthsConfirmation phase (III)Infectious DiseasesPulmonologyUrology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Fakultni Nemocnice Ostrava
Ustav klinicke imunologie a alergologie
Hlučín, Czechia
Fakultni Nemocnice Hradec Kralove
. Depart. Allergology and Clinical Immunology
Hradec Králové, Czechia
Nemocnice Na Homolce
Oddělení Klinické biochemie, hematologie a imunologie
Jinonice, Czechia
Sponsor: Aumed a.s.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.